10 sources retrieved · Most recent: April 2026 · Index updated 16 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
12PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLETranscription Factor
DATA QUALITY✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
protein bindingregulation of transcription by RNA polymerase IIcell differentiationDNA-binding transcription factor activity, RNA polymerase II-specificneurodegenerative diseaseFamilial hemophagocytic lymphohistiocytosisSplenomegalyBENTA disease
SPIC (Spi-C transcription factor) is a DNA-binding transcription factor that controls the development of red pulp macrophages required for red blood cell recycling and iron homeostasis. SPIC binds to PU-box sequences (5'-GAGGA[AT]-3') and regulates transcription through RNA polymerase II, including regulation of VCAM1 gene expression. In the immune context, SPIC expression is downregulated when Kupffer cells transition from a resident macrophage phenotype toward a monocyte-like state 1. Mechanistically, SPIC nuclear translocation can be promoted via PKC-mediated phosphorylation at T191, which enhances NK cell adhesion and cytotoxicity toward hepatic stellate cells through modulation of Itga4-VCAM1 binding in liver fibrosis models 2. SPIC represents a key transcriptional regulator integrating innate immune cell identity and function with iron metabolism homeostasis. Its expression status serves as a marker of macrophage differentiation state, with implications for understanding immune cell plasticity in response to inflammatory signals. Further research is needed to clarify the full spectrum of SPIC target genes and its role in disease pathology beyond macrophage development.
1
EP3 receptor signaling promotes SPIC nuclear translocation via PKC-mediated phosphorylation at T191, enhancing NK cell adhesion and cytotoxicity through Itga4-VCAM1 binding in liver fibrosis
PMID: 354206332
SPIC expression is downregulated in Kupffer cells during differentiation toward a monocyte-like phenotype in response to TLR8 agonist treatment
PMID: 38697771⚠Limited data available — This gene has 2 indexed publications. Summary and analysis may be incomplete.
neurodegenerative diseaseOpen Targets
Familial hemophagocytic lymphohistiocytosisOpen Targets
BENTA diseaseOpen Targets
Beta-thalassemia - X-linked thrombocytopeniaOpen Targets
beta-thalassemia-X-linked thrombocytopenia syndromeOpen Targets
dominant beta-thalassemiaOpen Targets
acute erythroleukemiaOpen Targets
erythroleukemia, familial, susceptibility toOpen Targets
hemoglobin H diseaseOpen Targets
congenital neutropenia-myelofibrosis-nephromegaly syndromeOpen Targets
Recurrent infections-myelofibrosis-nephromegaly syndromeOpen Targets
activated PI3K-delta syndromeOpen Targets
autoimmune lymphoproliferative syndrome type 4Open Targets
RAS-associated autoimmune leukoproliferative diseaseOpen Targets
Hemoglobin C - beta-thalassemiaOpen Targets
hemoglobin C-beta-thalassemia syndromeOpen Targets
hereditary neutrophiliaOpen Targets
Neutropenia - monocytopenia - deafnessOpen Targets
neutropenia-monocytopenia-deafness syndromeOpen Targets
No pathogenic variants reported on ClinVar for this gene.